Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
about
Vascular Inflammation: A Novel Access Route for NanomedicineSalvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial.Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors.
P2860
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
@en
type
label
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
@en
prefLabel
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
@en
P2860
P1433
P1476
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
@en
P2093
Richard Kones
P2860
P2888
P304
P356
10.1007/S40265-015-0429-3
P50
P577
2015-07-01T00:00:00Z
P5875
P6179
1032234344